- Home
- SQNS vs CASI Comparison
SQNS vs CASI Comparison
Compare SQNS & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- CASI
- Stock Information
- Founded
- SQNS 2003
- CASI 1991
- Country
- SQNS France
- CASI China
- Employees
- SQNS N/A
- CASI N/A
- Industry
- SQNS Semiconductors
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- SQNS Technology
- CASI Health Care
- Exchange
- SQNS Nasdaq
- CASI Nasdaq
- Market Cap
- SQNS 70.9M
- CASI 58.8M
- IPO Year
- SQNS 2011
- CASI 1996
- Fundamental
- Price
- SQNS $3.03
- CASI $3.00
- Analyst Decision
- SQNS Strong Buy
- CASI Strong Buy
- Analyst Count
- SQNS 1
- CASI 1
- Target Price
- SQNS $7.50
- CASI $6.00
- AVG Volume (30 Days)
- SQNS 168.6K
- CASI 54.4K
- Earning Date
- SQNS 11-05-2024
- CASI 11-15-2024
- Dividend Yield
- SQNS N/A
- CASI N/A
- EPS Growth
- SQNS N/A
- CASI N/A
- EPS
- SQNS 1.65
- CASI N/A
- Revenue
- SQNS $30,555,000.00
- CASI $22,055,000.00
- Revenue This Year
- SQNS $10.14
- CASI N/A
- Revenue Next Year
- SQNS $8.54
- CASI $134.79
- P/E Ratio
- SQNS $1.78
- CASI N/A
- Revenue Growth
- SQNS N/A
- CASI N/A
- 52 Week Low
- SQNS $0.85
- CASI $2.05
- 52 Week High
- SQNS $7.43
- CASI $8.19
- Technical
- Relative Strength Index (RSI)
- SQNS 54.44
- CASI 34.42
- Support Level
- SQNS $2.86
- CASI $2.86
- Resistance Level
- SQNS $3.11
- CASI $3.47
- Average True Range (ATR)
- SQNS 0.20
- CASI 0.48
- MACD
- SQNS -0.03
- CASI -0.00
- Stochastic Oscillator
- SQNS 38.36
- CASI 28.21
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.